Your briefing

Sarah Jessica Parker, 60, loves this lip color that plumps and softens her pout
Lifestyle 3 weeks ago
Sarah Jessica Parker, 60, loves this lip color that plumps and softens her pout
Full Coverage

Hankook Tires Survived the Safari Rally’s Brutal Test and Proved They’re Built Different
World 3 weeks ago
Hankook Tires Survived the Safari Rally’s Brutal Test and Proved They’re Built Different
Full Coverage

Is Ford Stock a Buy Now?
Finance 3 weeks ago
Is Ford Stock a Buy Now?
Full Coverage

Ten killed as Russia strikes Ukrainian cities in latest wave of drone and missile attacks
MOSCOW — At least 10 people were killed and more than 50 injured after Russia launched another wave of missile and drone attacks across Ukraine over t...
World 3 weeks ago
Ten killed as Russia strikes Ukrainian cities in latest wave of drone and missile attacks
Full Coverage

Trending

1. Joann's closing
2. Texas Tech basketball
3. UNC basketball
4. Monster Hunter Wilds
5. Ketamine
6. Macron
7. UPMC Memorial shooting
8. Eagles
9. Hims stock
10. Joel Embiid

Popular News

BrightGene präsentiert positive Phase-2-Daten für den Dual-G...
3 weeks ago
BrightGene präsentiert positive Phase-2-Daten für den Dual-GLP-1R/GIPR-Agonisten zur Gewichtsregulation und Behandlung von Typ-2-Diabetes sowie präklinische Daten für ein neues Amylin-Analogon bei den 85 Wissenschaftlichen Sitzungen der American Diabetes Association

The mortgage market hopes for rate cuts amid war moves
3 weeks ago
The mortgage market hopes for rate cuts amid war moves

Ukraine returns bodies of 3 Russian soldiers repatriated as ...
3 weeks ago
Ukraine returns bodies of 3 Russian soldiers repatriated as remains of Ukrainians, Interior Ministry says

BrightGene presenteert positieve fase 2 gegevens voor de dua...
3 weeks ago
BrightGene presenteert positieve fase 2 gegevens voor de duale GLP-1R/GIPR agonist voor gewichtsbeheersing en type 2 diabetes, en preklinische gegevens voor een nieuw amylin-analoog tijdens de 85e wetenschappelijke sessies van de American Diabetes Association

BrightGene présente des données positives de phase 2 pour so...
3 weeks ago
BrightGene présente des données positives de phase 2 pour son agoniste double GLP-1R/GIPR dans la gestion du poids et le diabète de type 2, ainsi que des données précliniques pour un nouvel analogue de l'amylin, lors de la 85 e édition des Sessions Scientifiques de l'American Diabetes Association
About Us · Contact Us · Terms & Conditions · Help · Privacy ·

© Latest News Search Engine - Global and Local Breaking News 2025. All rights are reserved